Doyle Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-2,856
| Closed | -$220K | – | 193 |
|
|
2020
Q2 | $220K | Sell |
2,856
-958
| -25% | -$73.8K | 0.03% | 166 |
|
|
2020
Q1 | $285K | Buy |
3,814
+388
| +11% | +$29K | 0.05% | 139 |
|
|
2019
Q4 | $223K | Sell |
3,426
-142,686
| -98% | -$9.29M | 0.03% | 195 |
|
|
2019
Q3 | $9.26M | Sell |
146,112
-3,131
| -2% | -$198K | 1.28% | 36 |
|
|
2019
Q2 | $10.1M | Sell |
149,243
-1,092
| -0.7% | -$73.8K | 1.39% | 32 |
|
|
2019
Q1 | $9.86M | Sell |
150,335
-1,409
| -0.9% | -$92.4K | 1.43% | 33 |
|
|
2018
Q4 | $9.49M | Sell |
151,744
-8,011
| -5% | -$501K | 1.6% | 24 |
|
|
2018
Q3 | $12.3M | Buy |
159,755
+2,529
| +2% | +$195K | 1.92% | 17 |
|
|
2018
Q2 | $11.1M | Buy |
157,226
+5,829
| +4% | +$413K | 1.84% | 20 |
|
|
2018
Q1 | $11.4M | Buy |
151,397
+6,199
| +4% | +$467K | 1.92% | 21 |
|
|
2017
Q4 | $10.4M | Sell |
145,198
-2,193
| -1% | -$157K | 1.76% | 22 |
|
|
2017
Q3 | $11.9M | Buy |
147,391
+8,178
| +6% | +$663K | 2.09% | 18 |
|
|
2017
Q2 | $9.85M | Buy |
139,213
+19,463
| +16% | +$1.38M | 1.83% | 22 |
|
|
2017
Q1 | $8.13M | Buy |
+119,750
| New | +$8.13M | 1.66% | 20 |
|